普米克令舒吸入佐治小儿毛细支气管炎疗效分析
|
摘要
目的对普米克令舒吸入佐治小儿毛细支气管炎的临床效果进行分析和探讨。方法方便选取该院对收治的52例患者进行分析研究,患者就诊时间为2016年4月—2018年4月,依据随机数表法对这些患者进行分组,实验组和对照组患者各26例。其中,对对照组患者进行常规治疗,包括抗病毒、抗感染、吸氧、止咳化痰等内容。对实验组患者在常规治疗的基础上采用普米克令舒吸入方式进行治疗,然后对两组患者治疗总有效率、不良反应发生情况、临床症状改善情况以及患儿心率恢复时间等进行观察和比较。结果通过对实验组患者实施普米克令舒吸入治疗,其咳嗽、气促、心率不稳、肺部湿罗音等临床症状改善情况显著优于对照组,恢复时间较短,分别为(2.38±0.8)、(32.46±1.0)、(95.14±1.7)、(75.60±2.43)vs(2.63±1.2)、(12.76±1.0)、(97.62±2.6)、(87.92±2.32)(P<0.05);实验组患者出现胃肠道和嗜睡等不良反应发生概率与对照组患者基本相同,分别为19%、17%,两组之间差异无统计学意义(χ~2=0.380,P>0.05);实验组患者治疗总有效率为96%、而对照组仅为85%,两组之间差异有统计学意义(χ~2=5.380,P<0.05)。结论针对小儿毛细支气管炎患者,采用普米克令舒吸入方式进行治疗能够显著改善患儿临床症状,提高患儿治疗总有效率,明显缩短病程,促进患儿健康恢复,治疗效果显著,因而具有很高的临床应用价值。
Objective To analyze and explore the clinical effect of Pulmicort inhalation in the treatment of children with bronchiolitis. Methods A total of 52 patients were convenient election enrolled in our hospital. The patients were enrolled from April 2016 to April 2008. The patients were divided into groups according to the random number table. There were 26 patients in the experimental group and the control group. Among them, the control group patients were routinely treated, including anti-virus, anti-infection, oxygen inhalation, cough and phlegm. The patients in the experimental group were treated with Pulmicort Respiratory Inhalation on the basis of routine treatment, and then the total effective rate, adverse reaction,improvement of clinical symptoms and recovery time of heart rate of the two groups were observed and compared. Results The clinical symptoms of cough, shortness of breath, unstable heart rate, and wet rales of the lungs were significantly better than those of the control group by the implementation of Pulmicort Respiratory Inhalation in the experimental group, the recovery time was shorter,(2.38± 0.8),(32.46±1.0),(95.14±1.7),(75.60±2.43) vs(2.63±1.2),(12.76±1.0),(97.62±2.6),(87.92±2.32)(P<0.05), significant difference between the two groups; experimental group patients of the incidence of adverse reactions such as gastrointestinal tract and lethargy was basically the same as that of the control group, 19% and 17%,respectively. There was no significant difference between the two groups.(χ~2=5.380, P>0.05); the total effective rate of the experimental group was 96%, while the control group was only 85%. There was a significant difference between the two groups. The significance of learning is significant(χ~2=5.380,P<0.05). Conclusion For patients with bronchiolitis in children, treatment with Pulmicort Respiratory Inhalation can significantly improve the clinical symptoms of children, improve the total effective rate of treatment, significantly shorten the course of disease, promote the healthy recovery of children, and have a significant therapeutic effect, with high clinical value.
Objective To analyze and explore the clinical effect of Pulmicort inhalation in the treatment of children with bronchiolitis. Methods A total of 52 patients were convenient election enrolled in our hospital. The patients were enrolled from April 2016 to April 2008. The patients were divided into groups according to the random number table. There were 26 patients in the experimental group and the control group. Among them, the control group patients were routinely treated, including anti-virus, anti-infection, oxygen inhalation, cough and phlegm. The patients in the experimental group were treated with Pulmicort Respiratory Inhalation on the basis of routine treatment, and then the total effective rate, adverse reaction,improvement of clinical symptoms and recovery time of heart rate of the two groups were observed and compared. Results The clinical symptoms of cough, shortness of breath, unstable heart rate, and wet rales of the lungs were significantly better than those of the control group by the implementation of Pulmicort Respiratory Inhalation in the experimental group, the recovery time was shorter,(2.38± 0.8),(32.46±1.0),(95.14±1.7),(75.60±2.43) vs(2.63±1.2),(12.76±1.0),(97.62±2.6),(87.92±2.32)(P<0.05), significant difference between the two groups; experimental group patients of the incidence of adverse reactions such as gastrointestinal tract and lethargy was basically the same as that of the control group, 19% and 17%,respectively. There was no significant difference between the two groups.(χ~2=5.380, P>0.05); the total effective rate of the experimental group was 96%, while the control group was only 85%. There was a significant difference between the two groups. The significance of learning is significant(χ~2=5.380,P<0.05). Conclusion For patients with bronchiolitis in children, treatment with Pulmicort Respiratory Inhalation can significantly improve the clinical symptoms of children, improve the total effective rate of treatment, significantly shorten the course of disease, promote the healthy recovery of children, and have a significant therapeutic effect, with high clinical value.
引文
[1]杨莓.普米克令舒佐治小儿毛细支气管炎的临床效果分析[J]护理与临床,2015(6):56-58.
[2]刘喜梅.普米克令舒佐治小儿毛细支气管炎的疗效观察[J]中外医学研究,2015(29):58-60.
[3]李世富.普米克令舒吸入佐治小儿毛细支气管炎临床应用研究[J].大家健康,2016(3):12-15.
[4]杜文丽.普米克令舒吸入佐治小儿毛细支气管炎临床疗效分析[J].中国医学工程,2016(2):87-88.
[5]向志云.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].黑龙江医药,2018(31):49-50.
[6]刘小娟.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].中国中西医结合儿科学,2015(4):345-347.
[7]韩冬梅.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].经验交流,2017(6):78-79.
[8]王小良.普米克令舒吸入佐治小儿毛细支气管炎的临床研究[J].世界最新医学信息文摘,2016(79):155-158.
[9]李红.普米克令舒吸入佐治小儿毛细支气管炎33例临床效果观察[J].中国医学工程,2015(23):78-79.
[10]季红燕,张云霞.探讨普米克令舒雾化吸入佐治小儿毛细支气管炎的疗效[J].中外医学研究,2016(2):122-123.
[11]赵红.普米克令舒联合沙丁胺醇佐治小儿毛细支气管炎的临床疗效及安全性分析[J].中国民康医学,2015(27)57-58.
[2]刘喜梅.普米克令舒佐治小儿毛细支气管炎的疗效观察[J]中外医学研究,2015(29):58-60.
[3]李世富.普米克令舒吸入佐治小儿毛细支气管炎临床应用研究[J].大家健康,2016(3):12-15.
[4]杜文丽.普米克令舒吸入佐治小儿毛细支气管炎临床疗效分析[J].中国医学工程,2016(2):87-88.
[5]向志云.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].黑龙江医药,2018(31):49-50.
[6]刘小娟.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].中国中西医结合儿科学,2015(4):345-347.
[7]韩冬梅.普米克令舒吸入佐治小儿毛细支气管炎疗效观察[J].经验交流,2017(6):78-79.
[8]王小良.普米克令舒吸入佐治小儿毛细支气管炎的临床研究[J].世界最新医学信息文摘,2016(79):155-158.
[9]李红.普米克令舒吸入佐治小儿毛细支气管炎33例临床效果观察[J].中国医学工程,2015(23):78-79.
[10]季红燕,张云霞.探讨普米克令舒雾化吸入佐治小儿毛细支气管炎的疗效[J].中外医学研究,2016(2):122-123.
[11]赵红.普米克令舒联合沙丁胺醇佐治小儿毛细支气管炎的临床疗效及安全性分析[J].中国民康医学,2015(27)57-58.